| Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis GS Hazlewood, A Rezaie, M Borman, R Panaccione, S Ghosh, CH Seow, ... Gastroenterology 148 (2), 344-354. e5, 2015 | 245 | 2015 |
| Past and future burden of inflammatory bowel diseases based on modeling of population-based data S Coward, F Clement, EI Benchimol, CN Bernstein, JA Avina-Zubieta, ... Gastroenterology 156 (5), 1345-1353. e4, 2019 | 131 | 2019 |
| Budesonide for induction of remission in Crohn's disease A Rezaie, ME Kuenzig, EI Benchimol, AM Griffiths, AR Otley, AH Steinhart, ... Cochrane Database of Systematic Reviews, 2015 | 107 | 2015 |
| Budesonide for maintenance of remission in Crohn's disease ME Kuenzig, A Rezaie, CH Seow, AR Otley, AH Steinhart, AM Griffiths, ... Cochrane Database of Systematic Reviews, 2014 | 91 | 2014 |
| Rural and urban residence during early life is associated with risk of inflammatory bowel disease: a population-based inception and birth cohort study EI Benchimol, GG Kaplan, AR Otley, GC Nguyen, FE Underwood, ... The American journal of gastroenterology 112 (9), 1412, 2017 | 80 | 2017 |
| Comparative effectiveness of mesalamine, sulfasalazine, corticosteroids, and budesonide for the induction of remission in Crohn's disease: a Bayesian network meta-analysis S Coward, ME Kuenzig, G Hazlewood, F Clement, K McBrien, R Holmes, ... Inflammatory bowel diseases 23 (3), 461-472, 2017 | 49 | 2017 |
| Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration ME Kuenzig, SM Lee, B Eksteen, CH Seow, C Barnabe, R Panaccione, ... BMC gastroenterology 16 (1), 1-9, 2016 | 45 | 2016 |
| The impact of inflammatory bowel disease in Canada 2018: direct costs and health services utilization ME Kuenzig, EI Benchimol, L Lee, LE Targownik, H Singh, GG Kaplan, ... Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019 | 44 | 2019 |
| The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD MW Carroll, ME Kuenzig, DR Mack, AR Otley, AM Griffiths, GG Kaplan, ... Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019 | 41 | 2019 |
| Co-occurrence of asthma and the inflammatory bowel diseases: a systematic review and meta-analysis ME Kuenzig, K Bishay, R Leigh, GG Kaplan, EI Benchimol, CSRR Team Clinical and translational gastroenterology 9 (9), 2018 | 32 | 2018 |
| Asthma is associated with subsequent development of inflammatory bowel disease: a population-based case–control study ME Kuenzig, C Barnabe, CH Seow, B Eksteen, ME Negron, A Rezaie, ... Clinical Gastroenterology and Hepatology 15 (9), 1405-1412. e3, 2017 | 31 | 2017 |
| The impact of inflammatory bowel disease in Canada 2018: A scientific report from the Canadian gastro-intestinal epidemiology consortium to Crohn’s and colitis Canada EI Benchimol, CN Bernstein, A Bitton, SK Murthy, GC Nguyen, K Lee, ... Journal of the Canadian Association of Gastroenterology 2 (Supplement_1), S1-S5, 2019 | 27 | 2019 |
| Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study EI Benchimol, ME Kuenzig, CN Bernstein, GC Nguyen, A Guttmann, ... Clinical epidemiology 10, 1613, 2018 | 26 | 2018 |
| Long-term outcomes of pediatric inflammatory bowel disease S Nasiri, ME Kuenzig, EI Benchimol Seminars in pediatric surgery 26 (6), 398-404, 2017 | 26 | 2017 |
| The impact of inflammatory bowel disease in Canada 2018: indirect costs of IBD care ME Kuenzig, L Lee, W El-Matary, AV Weizman, EI Benchimol, GG Kaplan, ... Journal of the Canadian Association of Gastroenterology 2 (Supplement_1 …, 2019 | 25 | 2019 |
| Longitudinal trends in the direct costs and health care utilization ascribable to inflammatory bowel disease in the biologic era: Results from a Canadian population–based analysis LE Targownik, GG Kaplan, J Witt, CN Bernstein, H Singh, A Tennakoon, ... Official journal of the American College of Gastroenterology| ACG 115 (1 …, 2020 | 22 | 2020 |
| Combined biologic and immunomodulatory therapy is superior to monotherapy for decreasing the risk of inflammatory bowel disease-related complications LE Targownik, EI Benchimol, CN Bernstein, H Singh, A Tennakoon, ... Journal of Crohn's and Colitis 14 (10), 1354-1363, 2020 | 20 | 2020 |
| Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis P Gu, ME Kuenzig, GG Kaplan, M Pimentel, A Rezaie Inflammatory bowel diseases 24 (6), 1280-1290, 2018 | 20 | 2018 |
| The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory bowel disease LE Targownik, EI Benchimol, J Witt, CN Bernstein, H Singh, L Lix, ... Inflammatory bowel diseases 25 (10), 1718-1728, 2019 | 19 | 2019 |
| Risk of venous thromboembolism after hospital discharge in patients with inflammatory bowel disease: a population-based study JD McCurdy, ME Kuenzig, G Smith, S Spruin, SK Murthy, M Carrier, ... Inflammatory bowel diseases 26 (11), 1761-1768, 2020 | 17 | 2020 |
Gilaad G KaplanProfessor, University of CalgaryVerified email at ucalgary.ca
